A brain-cell building block may offer a new way to combat Alzheimer's and Parkinson's by redirecting toxic proteins toward healthy functions.
The Discovery
Scientists at Baylor College of Medicine found that tubulin, the protein that builds microtubules—the cell's internal transport tracks—can prevent Tau and alpha-synuclein from forming harmful clumps. Instead, tubulin encourages these proteins to perform their normal jobs in healthy neurons. The study, published in Nature Communications, suggests a shift from blocking droplet formation to boosting tubulin levels as a potential therapeutic strategy.
Lead author Dr. Lathan Lucas and co-corresponding author Dr. Allan Ferreon used biochemical, biophysical, and neuron-based assays. They discovered that when tubulin is scarce—as in Alzheimer's—Tau and alpha-synuclein aggregate. But when tubulin is present, these proteins support microtubule assembly instead. Ferreon notes, "Tubulin redirects the activity of these proteins by giving them something productive to do."
Why It Matters
Alzheimer's and Parkinson's are linked to toxic protein clumps, but current efforts to prevent droplet formation might disrupt normal brain functions. This research highlights a potential selective therapy that curbs toxicity while preserving protein roles. For you, understanding this mechanism could inform future brain-health strategies, emphasizing the importance of cellular balance over simple removal.
What You Can Do
While this is early research, it underscores supporting overall brain health. Maintain a balanced lifestyle with regular exercise, adequate sleep, and cognitive challenges. Staying informed about emerging science helps you make evidence-based choices for your brain.
Source: ScienceDaily Mind & Brain
Curious about your own brain? Take our free adaptive IQ test or try 306 brain training levels.